Calcium Hydroxyapatite

Calcium hydroxyapatite (CaHA) is a biomaterial with over 30 years of clinical use in orthopedics, neurosurgery, dentistry, ophthalmology and otolaryngology.

Ingredients:
The Calcium hydroxyapatite dermal filler is composed of nonporous Calcium hydroxyapatite microspheres with particle diameters ranging from 25 to 45 p. The microspheres are suspended in a gel consisting of water, glycerin and sodium carboxymeth-ylcellulose. The CaHA dermal fillers are sterile, apyrogenic injections, semi-solid, biodegradable dermal implants, intended for sub-dermal and deep dermal use. The implant is comprised of synthetic calcium hydroxyapatite (CaHA) microspheres (55.7%, particle sizes: 25-45 microns), suspended in an aqueous carrier gel.
The CaHA dermal fillers are sterilized by moist heat and are intended for single use for one patient only.

Mode of action:
Following implantation, the Calcium hydroxyapatite microspheres form a scaffold supporting fibroblast ingrowth, which gradually replaces the carrier vehicle over a 2-3 month period. As the fibroblasts proliferate, they generate collagen fibers. Over time, the calcium hydroxyapatite is dissolved into calcium and phosphate ions though normal metabolic processes. By this time, a natural and physically sound matrix will have typically been established, providing the skin with the desired thickness and elasticity.

Product Configuration:
2 syringes of 1.25 ml, instructions for use, needles.

calcium

CONTACT US

Yosef Levi 23 Str.,
Kiryat Bialik, 2751123 Israel

Tel.: +972-(0) 46893930
Tel.: +972-(0) 46893931

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Subscribe our newsletter

© 2017 DR. Korman. All Rights Reserved